Eight join JPM on $8.5bn Merck deal

© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Eight join JPM on $8.5bn Merck deal

US drugs group Merck has completed senior syndication of its $7bn acquisition facility — and rolled over a $1.5bn CP backstop facility — with eight banks joining sole underwriter JPMorgan on the deal. The loan has now been launched to general syndication, which Merck expects to wrap up in the next few weeks.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • European securitization issuance database
  • Daily newsletters across markets and asset classes
  • 1 weekly securitization podcast

Related articles

Gift this article